Literature DB >> 19475617

Epidemic spread of hepatitis C virus genotype 3a and relation to high incidence of hepatocellular carcinoma in Pakistan.

Anis Khan1, Yasuhito Tanaka, Zahid Azam, Zaigham Abbas, Fuat Kurbanov, Uzma Saleem, Saeed Hamid, Wasim Jafri, Masashi Mizokami.   

Abstract

Studies conducted in different populations worldwide revealed an association between HCV genotype 1 and the development of hepatocellular carcinoma (HCC) than in infection with other HCV genotypes. There are reports which reveal the association of HCV genotype 3a (HCV-3a) with hepatic steatosis and fibrosis but its relation with the development of HCC has not been investigated. In Pakistan, where the incidence of HCC is increasing, 189 patients with chronic liver disease including 82 with HCC were enrolled. HCV genotypes were determined by phylogeny in the NS5B region and the epidemic history of HCV-3a was examined using coalescent theory based methods. HCV-3a was the predominant genotype (81.4%) in the cohort studied, followed by 3b (9.3%), 3k (2.3%), 1a (1.5%), 1c (1.5%), 1b (0.8%), and 2a (0.8%) where 76% of HCC and 86% of non-HCC were infected with HCV-3a. The significant factors associated with HCC were older age (mean +/- SD) 55.8 (+/-9.9) (P < 0.0001), and male gender (P < 0.001). HCV RNA was significantly higher in patients with HCC and chronic hepatitis than in liver cirrhosis (P < 0.0001). Molecular evolutionary analysis revealed a distinct phylogenetic cluster of HCV-3a in Pakistan and an estimation of the effective number of HCV infections indicated the appearance of HCV-3a in this region around 1920s and a rapid exponential growth in the 1950s. This indicates that the epidemic spread of HCV-3a occurred earlier in Pakistan than in other countries in which this genotype has been reported. HCV-3a which spread earlier in Pakistan may be associated with an increasing incidence of HCC. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19475617     DOI: 10.1002/jmv.21466

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  22 in total

1.  Hepatitis C viremia and genotype distribution among a sample of nonmedical prescription drug users exposed to HCV in rural Appalachia.

Authors:  April M Young; Richard A Crosby; Carrie B Oser; Carl G Leukefeld; Dustin B Stephens; Jennifer R Havens
Journal:  J Med Virol       Date:  2012-09       Impact factor: 2.327

Review 2.  Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review.

Authors:  Harleen K Dyal; Maria Aguilar; Taft Bhuket; Benny Liu; Edward W Holt; Sharon Torres; Ramsey Cheung; Robert J Wong
Journal:  Dig Dis Sci       Date:  2015-07-03       Impact factor: 3.199

Review 3.  Hepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent data.

Authors:  Muhammad Umer; Mazhar Iqbal
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

4.  Hepatocellular carcinoma in pakistan: where do we stand?

Authors:  Amna Subhan Butt; Zaigham Abbas; Wasim Jafri
Journal:  Hepat Mon       Date:  2012-10-10       Impact factor: 0.660

5.  Hepatitis C viral heterogeneity based on core gene and an attempt to design small interfering RNA against strains resistant to interferon in rawalpindi, pakistan.

Authors:  Sobia Kanwal; Tariq Mahmood
Journal:  Hepat Mon       Date:  2012-06-30       Impact factor: 0.660

Review 6.  Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries.

Authors:  Masao Omata; Tatsuo Kanda; Osamu Yokosuka; Darrell Crawford; Mamun Al-Mahtab; Lai Wei; Alaaeldin Ibrahim; George K K Lau; Barjesh C Sharma; Saeed S Hamid; Wan-Long Chuang; A Kadir Dokmeci
Journal:  Hepatol Int       Date:  2015-05-05       Impact factor: 9.029

7.  APASL consensus statements and management algorithms for hepatitis C virus infection.

Authors:  Masao Omata; Tatsuo Kanda; Ming-Lung Yu; Osamu Yokosuka; Seng-Gee Lim; Wasim Jafri; Ryosuke Tateishi; Saeed S Hamid; Wan-Long Chuang; Anuchit Chutaputti; Lai Wei; Jose Sollano; Shiv Kumar Sarin; Jia-Horng Kao; Geoffrey W McCaughan
Journal:  Hepatol Int       Date:  2012-03-01       Impact factor: 9.029

8.  Spatiotemporal Reconstruction of the Introduction of Hepatitis C Virus into Scotland and Its Subsequent Regional Transmission.

Authors:  Anna L McNaughton; Iain Dugald Cameron; Elizabeth B Wignall-Fleming; Roman Biek; John McLauchlan; Rory N Gunson; Kate Templeton; Harriet Mei-Lin Tan; E Carol McWilliam Leitch
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

9.  Emergence of genetically variant Hepatitis C virus population in response to increased antiviral drug pressure, Pakistan.

Authors:  Muhammad Ali; Irshad Ur Rehman; Muhammad Idrees
Journal:  Virus Genes       Date:  2014-02-16       Impact factor: 2.332

10.  Phylogeography, risk factors and genetic history of hepatitis C virus in Gabon, central Africa.

Authors:  Richard Njouom; Mélanie Caron; Guillaume Besson; Guy-Roger Ndong-Atome; Maria Makuwa; Régis Pouillot; Dieudonné Nkoghé; Eric Leroy; Mirdad Kazanji
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.